Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Mia Cassella told Newsweek: "Cancer might take away things like my hair or my energy, but it couldn't take away my passion for lifting and working out." ...

Health experts say popular weight-loss drugs like Ozempic and Wegovy are safe, but the FDA warns counterfeits are becoming more widespread.

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...

Novo Nordisk is planning a new Phase III trial for CagriSema ... the weight loss seen after 68 weeks might not have been the ...

Weight loss drugs have surged in popularity, with millions turning to medications like Ozempic and Wegovy in hopes of shedding excess weight and managing diabetes. These drugs, classified as GLP-1 ...

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with obesity or have a health ...

The trial showed that patients treated with CagriSema exhibited weight loss of 22.7% after 68 weeks ... your rights to seek a recovery. There is no cost or obligation to participate.

The trial showed that patients treated with CagriSema exhibited weight loss of 22.7% after 68 weeks ... that you serve as a lead plaintiff. NO COST TO YOU: If you are a class member, you may ...

The experimental CagriSema shot missed Novo’s own expectations for weight loss and performed roughly in-line with Eli Lilly & Co.’s Zepbound, which is already on the market and competes with the ...

While the initial market reaction to Novo’s more enhanced CagriSema weight loss treatment was negative, we believe this is a more potent formulation that can better compete with Lilly’s suite.